SavedAdd your journal

Journals / Genel Tıp Dergisi / 2008 / Cilt: 18 - Sayı: 4

The insulin-like growth factors (IGFs): Exercise metabolism and effects on muscle tissue

İnsülin benzeri büyüme faktörleri (IGF): Egzersiz metabolizması ve kas dokusu üzerine etkileri

SULTAN HARBİLİ
Pages
177–184
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Owing to this condition, exercise plays an effective role on preventing muscle atrophy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The development and growing up of organism was regulated by hormones and factors effective in growth along axis of hypothalamus- hypophysis.
📊
Key Findings & Data:Main Findings: Insulin–like growth factors (IGFs) is synthesized by liver and many of tissue are effective in somatic growth.
💡
Conclusion & Impact:Owing to this condition, exercise plays an effective role on preventing muscle atrophy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The development and growing up of organism was regulated by hormones and factors effective in growth along axis of hypothalamus- hypophysis. In this study, effects of IGFs were aimed to investigate on bone and muscle metabolism and its regulation and response to exercise. Main Findings: Insulin–like growth factors (IGFs) is synthesized by liver and many of tissue are effective in somatic growth. IGFs have two important forms as IGF-I and IGF-II. IGF-II is effective on intrauterine growth, whereas IGF-I is more effective on postnatal growth. IGFs binding proteins were transported to target organs. Six binding proteins have been defined (IGF 1-6). The binding proteins have three different receptor in cell membrane, insulin receptor; Type-I receptor and Type-II receptor. IGFs affected via autocrine and paracrine mechanisms on bone and muscle. Conclusion: The effect of IGF on muscle tissue increase with mechanic stress (resistance exercise). Owing to this condition, exercise plays an effective role on preventing muscle atrophy.

Özet

Amaç: Organizmanın büyümesi ve gelişmesi, hipotalamus- hipofiz ekseni boyunca büyümede etkili bir dizi hormon ve faktör tarafından regüle edilir. Bu derlemede IGF’nin, kemik ve kas metabolizması ve egzersize cevabı üzerindeki etkilerinin incelenmesi amaçlanmıştır. Ana bulgular: İnsülin benzeri büyüme faktörleri (IGF) somatik büyümede etkili olan, karaciğer ve birçok doku tarafından sentezlenebilen faktörlerdir. IGF-I ve IGF-II olarak iki önemli forma sahiptir. IGF-I daha çok postnatal, IGF-II ise intrauterin büyüme üzerinde etkilidir. IGF’ler serumda bağlayıcı proteinlere bağlanarak hedef organlara taşınır; 6 tane bağlayıcı protein tanımlanmıştır (IGF 1-6). Hücre membranında insülin reseptörü, Tip-I reseptörü ve Tip-II reseptörü olmak üzere 3 farklı reseptöre sahiptirler. Kemik ve kas gelişimindeki metabolik etkilerini parakrin ve otokrin mekanizmalar üzerinden gerçekleştirirler. Sonuç: IGF’nin kas dokusunda etkisi mekanik stresle (direnç egzersizleri) birlikte artar. Bundan dolayı kas kayıplarının önlenmesinde egzersiz etkin rol oynamaktadır.

🔖

Cite This Article

HARBİLİ, S. (2008). The insulin-like growth factors (IGFs): Exercise metabolism and effects on muscle tissue. Genel Tıp Dergisi, Cilt: 18 - Sayı: 4, 177–184. https://ajindex.com/articles/216179

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Cappola AR, Bandeen-Roche K, Wand GS, Volpato S, Frıed LP. Association of IGF-I Levels with Muscle Strength and Mobility in older Women. J Clin Endoc Metab 2001;86:4139-46
  2. Le Roith D. Insulin-like growth factors. N Engl J Med 1997;336:633–40
  3. Owino V, Yang SY, Goldspink G. Age-related loss of skeletal muscle function and inability to express the autocrine form of insulin-like growth factor-I(MGF) in response to mechanical overload. FEBS Letters 2001;505:259-63
  4. Wang HS, Chard. TIGFs ve IGF-binding proteins in the regulation of human ovarian and endometrial function. J Endoc. 1999;161:1-13
  5. Miyao M, Hosoi T, Inoue S, Hoshino S, Ouchi Y. Polymorphism of Insulin-like Growth Factor I Gene and Bone Mineral Density. Calcif Tissue Int 1998;63:306–11
  6. Whitler RJ, Meikle AW, Watts NB. Pituitary function, İn “Tietz fundamentals of clinical chemistry” 4th ed, Burtis CA, Ashwood ER(ed), WB saunders Company, Philadelphia.1996;626-39
  7. Gluckman PD, Breier BH, Davis SR. Physiology of somatotropic axis with particular reference to the ruminant. J Dairy Sci 1987; 70:442-66
  8. Le Roıth D, Bondy C, Yakar S, Lıu J, Butler A. The. Somatomedin Hypothesis: 2001. Endoc Rev 2001;22:53–74
  9. Clemmons DR. Peptide growth factors in “Joslin’s Diabetes Mellitus” Ed by Kahn CR, Gordon,CW, 13th Ed, 1994;177-92, A Waverly Company, Philadelphia
  10. Beaune B, Blone S, Fellmann N, Bedu M, Coudert J. Serum insulinlike growth factor-I and physical performance in prepubertal Bolivian girls of a high and low socio-economic status. Eur JAppl Physiol 1997;76:98-102
  11. Khan AS, Sane DC, Wannenburg T, Sonntag WE. Growth hormone, insulin-like growth factor-I and aging cardiovascular system. Cardiovascular Res 2002;54:25-35
  12. Adams GR, Haddad F. The relationships among IGF-I, DNA content, and protein accumulation during skeletal muscle hypertrophy. JAppl Physiol 1996;81:2509-16
  13. Cheo P, Ocrant I, Fielder PJ, Neely EK, Gargosky SE, Deal CI. İnsulin like growth factors (IGF): Implications of aging, Psycho neuroendocrinology 1992;17:335-42
  14. Jones JI, Clemmons DR. İnsulin-like growth factor and their binding proteins, biological actions. Endocrine Rev 1995;16:3-34
  15. Clark R. The somotogenic hormones and insulin-like growth factor-1:stimulators of lymphopoieses and ımmune function. Endoc Rev 1997;18:157-79
  16. Rajaram S, Baylınk DJ, Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions. Endoc Rev 1997;18: